Integer (NYSE:ITGR – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 5.240-5.430 for the period, compared to the consensus estimate of 5.300. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Integer also updated its FY24 guidance to $5.24-5.43 EPS.
Integer Price Performance
ITGR traded up $0.31 during midday trading on Thursday, hitting $126.84. The company had a trading volume of 524,924 shares, compared to its average volume of 312,988. Integer has a twelve month low of $69.40 and a twelve month high of $133.53. The firm’s 50-day simple moving average is $127.37 and its 200-day simple moving average is $120.86. The company has a market capitalization of $4.25 billion, a PE ratio of 43.86, a P/E/G ratio of 1.86 and a beta of 1.08. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29.
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. The business had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. Integer’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.27 earnings per share. Equities research analysts predict that Integer will post 5.3 EPS for the current fiscal year.
Analyst Ratings Changes
Check Out Our Latest Research Report on ITGR
Insider Transactions at Integer
In other Integer news, Director Jean M. Hobby sold 11,960 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the transaction, the director now directly owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
- Five stocks we like better than Integer
- Dividend Payout Ratio Calculator
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- How to Plot Fibonacci Price Inflection Levels
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How to Evaluate a Stock Before BuyingÂ
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.